Viveve Medical - VIVE Stock Forecast, Price & News

0 brokerages have issued 1-year price objectives for Viveve Medical's shares. Their VIVE share price forecasts range from $5.25 to $5.25. On average, they anticipate the company's share price to reach $5.25 in the next year. This suggests a possible upside of 629.2% from the stock's current price.
View analysts price targets for VIVE or view top-rated stocks among Wall Street analysts.

Viveve Medical's stock was trading at $1.14 at the start of the year. Since then, VIVE stock has decreased by 36.8% and is now trading at $0.72.
View the best growth stocks for 2022 here.

Viveve Medical saw a drop in short interest in the month of July. As of July 15th, there was short interest totaling 77,800 shares, a drop of 38.3% from the June 30th total of 126,100 shares. Based on an average daily volume of 176,400 shares, the short-interest ratio is presently 0.4 days. Approximately 0.8% of the company's shares are sold short.
View Viveve Medical's Short Interest.

Viveve Medical is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022.
View our VIVE earnings forecast.

Viveve Medical will be holding an earnings conference call on Thursday, August 11th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

Viveve Medical, Inc. (NASDAQ:VIVE) issued its quarterly earnings results on Thursday, May, 12th. The company reported ($0.67) earnings per share (EPS) for the quarter. The business had revenue of $1.64 million for the quarter. Viveve Medical had a negative net margin of 353.45% and a negative trailing twelve-month return on equity of 132.32%.

Based on aggregate information from My MarketBeat watchlists, some companies that other Viveve Medical investors own include Corbus Pharmaceuticals (CRBP), Visa (V), HP (HPQ), Fortive (FTV), Lowe's Companies (LOW), SCYNEXIS (SCYX), Western Digital (WDC), Inovio Pharmaceuticals (INO), Viking Therapeutics (VKTX) and Novavax (NVAX).

(VIVE) raised $13 million in an IPO on Tuesday, June 14th 2016. The company issued 1,600,000 shares at a price of $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group acted as the underwriters for the IPO and Maxim Group was co-manager.

Viveve Medical trades on the NASDAQ under the ticker symbol "VIVE."

Shares of VIVE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of VIVE stock can currently be purchased for approximately $0.72.

Viveve Medical (NASDAQ:VIVE) has a market capitalization of $7.66 million and generates $6.43 million in revenue each year. The company earns $-22,030,000.00 in net income (profit) each year or ($2.55) on an earnings per share basis.

Viveve Medical employs 47 workers across the globe.

Viveve Medical's mailing address is 345 INVERNESS DRIVE SOUTH BUILDING B SUITE 250, ENGLEWOOD CO, 80112. The official website for the company is www.viveve.com. The company can be reached via phone at (720) 696-8100, via email at ir@viveve.com, or via fax at 720-696-8199.